Dr. Vishwanath Venketaraman has been a Professor at the College of Osteopathic Medicine of the Pacific at Western University from 2018 to the present. He graduated with his B.S. and M.S. in Biology from the University of Madras and obtained his Ph.D. in Immunology at the National Institute for Research on Tuberculosis. He and his team study the pathophysiology of tuberculosis in the context of HIV co-infection and type II diabetes. They recently conducted a clinical trial in HIV-positive individuals to test the efficacy of liposomal glutathione (L-GSH) in restoring the levels of GSH and improving the functions of immune cells. Currently, he continues the preclinical and clinical studies and tries to develop immunotherapeutic agents that can be used as adjuncts to prevent the development of active tuberculosis in individuals with HIV infection and people with type II diabetes. He has been awarded the Provost’s Distinguished Scholar Award from the Western University of Health Sciences in 2019 and the Best Professor Award of 2019. In his distinguished research career, he has authored more than 100 publications in international peer-reviewed journals.
Research Keywords & Expertise
Mycobacteriology
Tuberculosis
type 2 diabetes mellit...
host immune responses
Host-directed therapy
HIV and AIDS
Adjunctive therapy
Fingerprints
70%
Tuberculosis
18%
type 2 diabetes mellitus
11%
host immune responses
9%
Adjunctive therapy
5%
Host-directed therapy
5%
HIV and AIDS
Short Biography
Dr. Vishwanath Venketaraman has been a Professor at the College of Osteopathic Medicine of the Pacific at Western University from 2018 to the present. He graduated with his B.S. and M.S. in Biology from the University of Madras and obtained his Ph.D. in Immunology at the National Institute for Research on Tuberculosis. He and his team study the pathophysiology of tuberculosis in the context of HIV co-infection and type II diabetes. They recently conducted a clinical trial in HIV-positive individuals to test the efficacy of liposomal glutathione (L-GSH) in restoring the levels of GSH and improving the functions of immune cells. Currently, he continues the preclinical and clinical studies and tries to develop immunotherapeutic agents that can be used as adjuncts to prevent the development of active tuberculosis in individuals with HIV infection and people with type II diabetes. He has been awarded the Provost’s Distinguished Scholar Award from the Western University of Health Sciences in 2019 and the Best Professor Award of 2019. In his distinguished research career, he has authored more than 100 publications in international peer-reviewed journals.
Honors and Awards
Distinguished Teacher Award
Western University of Health Sciences
Distinguished Scholar Award
Western University of Health Sciences
Distinguished Faculty Award For Teaching And Education
College of Osteopathic Medicine of the Pacific, Western University of Health Sciences